Xenon Pharmaceuticals Inc. (XENE)
Market Closed
17 Jul, 20:00
$
68. 26
+1.28
+1.911%
$
5.31B Market Cap
- P/E Ratio
- Div Yield
1.34M Volume
-2.91 Eps
$ 66.98
Previous Close 
Want to track XENE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Xenon Pharmaceuticals Inc. (XENE) Statistics
Valuation metrics
Market Cap 5.31B
Enterprise value 4.85B
Trailing P/E (ttm) -14.52
Forward P/E -
PEG ratio 0.43
Price/Sales (ttm) -
Price/Book (mrq) 4.46
Enterprise Value/Revenue -
Enterprise Value/EBITDA -12.16
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.96M
Average volume (90 days) 1.15M
Price summary
52-Week low 30
52-Week high 72.66
Beta -
50-Day moving average 57.24
200-Day moving average 50.59
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.28%
Return on equity -0.49%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -4.39
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 12.53
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 27.79%
Book value per share (mrq) 15.32
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
